Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
130,702,820
-
Total 13F shares
-
57,920,959
-
Share change
-
-8,035,569
-
Total reported value
-
$801,022,755
-
Put/Call ratio
-
117%
-
Price per share
-
$13.83
-
Number of holders
-
139
-
Value change
-
-$114,549,555
-
Number of buys
-
67
-
Number of sells
-
62
Institutional Holders of Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) as of Q4 2020
As of 31 Dec 2020,
Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) was held by
139 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
57,920,959 shares.
The largest 10 holders included
HealthCor Management, L.P., FMR LLC, NEA Management Company, LLC, ORBIMED ADVISORS LLC, PICTET ASSET MANAGEMENT LTD, Point72 Asset Management, L.P., SUSQUEHANNA INTERNATIONAL GROUP, LLP, Avidity Partners Management LP, Connor, Clark & Lunn Investment Management Ltd., and KINGDON CAPITAL MANAGEMENT, L.L.C..
This page lists
139
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.